Home › Funds › Ally Bridge Group (NY) LLC › ASMB
Ally Bridge Group (NY) LLC position in ASMB
ASSEMBLY BIOSCIENCES INC · Health Care
Ally Bridge Group (NY) LLC reported holding 18,298 shares of ASMB (ASSEMBLY BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$430K, representing 0.57% of its reported portfolio and ranking #17 among its reported holdings. Ally Bridge Group (NY) LLC has disclosed ASMB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Ally Bridge Group (NY) LLC's ASMB position evolved
Ally Bridge Group (NY) LLC first disclosed a stake in ASMB in Q2 2026 at 140,000 shares (US$3.8M). Across 2 filings, Ally Bridge Group (NY) LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 18,298 shares valued at US$430K — a reduction of -121,702 shares quarter over quarter.. Notable position changes include a 87% trim in Q3 2026 (shares fell 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 140.00K | $3.85M | New |
| Q3 2026 | 18.30K | $429.82K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ASMB and 13F data
ASMB (ASSEMBLY BIOSCIENCES INC) is a Health Care company. 55 other funds we track also report a position in ASMB — the largest reported positions include GILEAD SCIENCES, INC. (US$116.9M), Farallon Capital Management (US$44.1M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$37.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ASMB
- GILEAD SCIENCES, INC. 4.98M sh · $116.91M · Q3 2026
- Farallon Capital Management 1.60M sh · $44.09M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 1.60M sh · $37.69M · Q3 2026
- Paradigm Biocapital Advisors LP 1.55M sh · $36.50M · Q3 2026
- Parkman Healthcare Partners LLC 796.26K sh · $18.70M · Q3 2026
- Commodore Capital LP 461.92K sh · $10.85M · Q3 2026
- Seven Fleet Capital Management LP 417.44K sh · $9.81M · Q3 2026
- DV EQUITIES, LLC 226.41K sh · $5.32M · Q3 2026
- Squadron Capital Management LLC 225.00K sh · $5.29M · Q3 2026
- B Group, Inc. 175.71K sh · $4.13M · Q3 2026
- MONIMUS CAPITAL MANAGEMENT, LP 47.58K sh · $1.12M · Q3 2026
More on Ally Bridge Group (NY) LLC
FAQ
How long has Ally Bridge Group (NY) LLC held ASMB?
Ally Bridge Group (NY) LLC has disclosed ASMB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Ally Bridge Group (NY) LLC's current position in ASMB?
As of Q3 2026, Ally Bridge Group (NY) LLC holds 18.30K shares of ASMB (ASSEMBLY BIOSCIENCES INC), valued at $429.82K, representing 0.57% of its reported portfolio and ranking #17.
Has Ally Bridge Group (NY) LLC been buying or selling ASMB?
In the latest 13F filing (Q3 2026), Ally Bridge Group (NY) LLC reduced its position in ASMB.
Which other funds hold ASMB?
Other major institutional holders of ASMB include GILEAD SCIENCES, INC., Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 55 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.